NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) Sees Large Decrease in Short Interest

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Free Report) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 188,400 shares, a drop of 20.6% from the May 31st total of 237,400 shares. Based on an average daily trading volume, of 364,300 shares, […]

Related Keywords

,Neurobo Pharmaceuticals Inc ,News Ratings For Neurobo Pharmaceuticals Daily ,Nasdaq ,Millennium Management ,Neurobo Pharmaceuticals ,Renaissance Technologies ,Neurobo Pharmaceuticals Stock Down ,Free Report ,Sigma Investments ,G Protein Coupled Receptor ,Neurobo Pharmaceuticals Daily ,Nasdaq Nrbo ,Nrbo ,Medical ,Stocks ,Options ,Put ,Call ,